Cocaine Use Disorder
83
19
21
48
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
21 trials with published results (25%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.8%
4 terminated out of 83 trials
92.3%
+5.8% vs benchmark
4%
3 trials in Phase 3/4
44%
21 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 48 completed trials
Clinical Trials (83)
Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
LDART for Stimulant Use Disorder
SXC-2023 Cocaine Interaction Study
Phase1, STP7 Cocaine Drug-Drug Interaction Study
Impact of Cocaine Use and Withdrawal on Sleep
Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
Contingency Management for Drug Use: Does Age Matter?
Exenatide For Reducing the Reinforcing Effects of Cocaine
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
Safety Profile of Psilocybin for Cocaine Use Disorder
Cariprazine for Comorbid Cocaine and Opioid Use Disorder
CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations
Treating Polysubstance Use Using a Novel Digital Technology
Temporal Window and Episodic Future Thinking in CUD
Cocaine and Pentoxifylline (BED IN 47)